PRESCRIBING · PART D · 2024
Total Rx claims
1,877
Beneficiaries
—
Total drug cost
$699K
Distinct drugs
41
Brand share
44.4%
Top prescribed drugs
Topiramate152 claims
Ubrogepant139 claims
Memantine Hcl125 claims
Erenumab-Aooe120 claims
Galcanezumab-Gnlm108 claims
QUALITY · MIPS · 2024
Final MIPS score
82.0
Quality
66.0
Cost
74.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.29%
Group
CROSS-REFERENCE